| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 4678-45-9 | 木藜蘆毒素?1/2乙酸加成化合物 | Grayanotoxane-3,5,6,10,14,16-hexol,(3b,6b,14R)-; GrayanotoxinIII (6CI,7CI); (-)-Grayanotoxin III; Andromedol; Deacetylandromedotoxin; Deacylasebotoxin I; FDA 1962; NSC 323778 |  | C20H34O6 | 詳情 | 供應(yīng)商 |
| 29708-82-5 | Grayanotoxane-3,5,6,7,10,16-hexol,(3b,6b,7a)- (9CI); 7,9aa-Methano-9aH-cyclopenta[b]heptalene-2,4,8,10,11,11ab(1H)-hexol, 2a,3,3ab,4,4ab,5,6,7b,8,9,10b,11a-dodecahydro-1,1,4b,8b-tetramethyl- (8CI); 7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxane-3,5,6,7,10,16-hexol deriv.; Dihydrodeacetyllyoniatoxin; Dihydrolyoniol B; Lyoniol B, dihydro- |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 30460-38-9 | Grayanotoxane-3,5,6,10,14,16-hexol,(3a,6b,14R)- (9CI); 7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxane-3,5,6,10,14,16-hexol deriv.; 3-Epigrayanotoxin III; 3-epi-GrayanotoxinIII |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 58962-34-8 | 6-酮前列腺素 | Prost-13-en-1-oic acid,9,11,15-trihydroxy-6-oxo-, (9a,11a,13E,15S)-; 6-Keto-PGF1a; 6-Ketoprostaglandin F1a; 6-Oxo-PGF1a; 6-Oxoprostaglandin F1a; 6-keto-Prostaglandin F1a |  | C20H34O6 | 詳情 | 供應(yīng)商 |
| 96087-34-2 | Prost-13-en-1-oic acid,5,6-epoxy-9,11,15-trihydroxy-, (9a,11a,13E,15S)- (9CI) |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 63983-53-9 | Prostan-1-oic acid,9,11-dihydroxy-6,15-dioxo-, (9a,11a)-; 13,14-Dihydro-6,15-dioxo-PGF1a |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 52162-11-5 | Prost-13-en-1-oic acid,9,11-epidioxy-15-hydroperoxy-, (9a,11a,13E,15S)-; 2,3-Dioxabicyclo[2.2.1]heptane,prost-13-en-1-oic acid deriv.; 15-Hydroperoxyprostaglandin R1; PGG1; Prostaglandin G1 |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 56932-60-6 | Prosta-5,13-dien-1-oicacid, 9,11,15,19-tetrahydroxy-, (5Z,9a,11a,13E,15S)- (9CI); 19-HydroxyprostaglandinF2a |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 55123-67-6 | Prost-13-en-1-oic acid,11,15,19-trihydroxy-9-oxo-, (11a,13E,15S)-; 11,15,19-Trihydroxy-9-ketoprost-13-enoicacid; 19-Hydroxy PGE1; 19-Hydroxyprostaglandin E1 |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 57930-92-4 | Prosta-5,13-dien-1-oicacid, 9,11,15,20-tetrahydroxy-, (5Z,9a,11a,13E,15S)- (9CI); 20-Hydroxy-PGF2a; 20-Hydroxyprostaglandin F2a |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 64625-53-2 | Prosta-5,13-dien-1-oicacid, 9,11,15,19-tetrahydroxy-, (5Z,9a,11a,13E,15S,19R)- (9CI); 19(R)-HYDROXY PROSTAGLANDIN F2ALPHA; 9ALPHA,11ALPHA,15S,19R-TETRAHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 64625-55-4 | Prost-13-en-1-oic acid,11,15,19-trihydroxy-9-oxo-, (11a,13E,15S,19R)-; 11a,15a,19b-Trihydroxy-9-oxo-13E-prostenoic acid |  | C20H34O6 | 詳情 | 供應(yīng)商 | |
| 54397-85-2 | (5Z,9Α,11RS,13E,15S)-9,11,15-三羥基血栓氧-5,13-二烯-1-烏蘇酸 | THROMBOXANE B2; THROMBOXANE B2; TXB2; 9ALPHA,11,15S-TRIHYDROXYTHROMBA-5Z,13E-DIEN-1-OIC ACID; [5Z,9ALPHA,11RS,13E,15S]-9,11,15-TRIHYDROXYTHROMBOXA-5,13-DIEN-1-OIC ACID; (5z,9α,11rs,13e,15s)-9,11,15-trihydroxythromboxa-5,13-dien-1-oic acid; (E)-7-[(2S,3S,4S)-4,6-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]oxan-3-yl]hept-5-enoic acid; TXB2, (5Z,9α,11RS,13E,15S)-9,11,15-Trihydroxythromboxa-5,13-dien-1-oic acid; (5Z,13E,15S)-9α,11,15-Trihydroxythromboxa-5,13-dien-1-oic acid |  | C20H34O6 | 詳情 | 供應(yīng)商 |